VCM
CDLX icon

Vetamer Capital Management’s Cardlytics CDLX Stock Holding History

Vetamer Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,918
Closed -$248K – 94
2023
Q2 		$248K Sell
3,918
-2,386
-38% -$145K 0.33% 60
2023
Q1 		$214K Sell
6,304
-835
-12% -$43.6K 0.29% 56
2022
Q4 		$413K Buy
7,139
+2,029
+40% +$125K 0.56% 46
2022
Q3 		$480K Buy
+5,110
New +$727K 0.53% 47

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vetamer Capital Management's CDLX Position: Q3 2023 in Review

Vetamer Capital Management sold out of Cardlytics (CDLX) in Q3 2023, closing a stake of 3,918 shares — an estimated $248K sold.

Vetamer Capital Management first reported a position in CDLX in Q3 2022 and held it in 4 quarters. The position peaked at $480K in Q3 2022. 112 funds tracked by Wall St. Rank hold CDLX as of Q3 2023.

  • Vetamer Capital Management reported no remaining Cardlytics position as of Q3 2023 after selling out during the quarter.
  • Vetamer Capital Management sold 3,918 Cardlytics shares in Q3 2023, an estimated $248K.
  • Vetamer Capital Management first reported a position in Cardlytics in Q3 2022 and held it in 4 quarters.
  • Vetamer Capital Management's Cardlytics position peaked at $480K in Q3 2022.
  • 112 funds tracked by Wall St. Rank held Cardlytics as of Q3 2023.

Based on Vetamer Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.